Quote & Headlines
StockTalk
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Cancer Stocks Finish a Tough QuarterAlan Brochstein • Mon, Oct 1, 2007
-
Sonus Is Undervalued At $4 - Call Options Are AttractiveBrett Scott • Thu, Aug 30, 2007
-
Sonus Pharmaceuticals: Tocosol Approval Looks PromisingMike Havrilla • Wed, Jul 11, 2007
To learn more about Seeking Alpha Pro, click here.
-
Cancer Stocks Finish a Tough QuarterAlan Brochstein • Mon, Oct 1, 2007
There are no Transcripts on SNUS.
There are no News articles on SNUS.